$SABS Balance Sheet | Understand Stock

$SABS

$2.79 -$0.05 (1.76%) Close

$SABS Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
Assets
Cash
Current assets
Cash and cash equivalents
Restricted cash
Short-term investments
Accounts receivable, net
Prepaid expenses
Accrued interest receivable
Prepaid expenses and other current assets
Total current assets
Marketable securities held in Trust Account

Deferred issuance cost
Long-term prepaid assets
Long-term investments
Operating lease right-of-use assets
Financing lease right-of-use assets
Property, plant and equipment, net
Total assets

Liabilities and Equity
Accrued offering costs and expenses
Current liabilities
Notes payable
Accounts payable
Forward share purchase liability
Accrued expenses and other current liabilities
Operating lease liabilities, current portion
Finance lease liabilities, current portion
Due to related party
Deferred grant income
Income tax payable
Total current liabilities
Deferred underwriting fee

Operating lease liabilities, noncurrent
Finance lease liabilities, noncurrent
Warrant liabilities
Notes payable, noncurrent
Total liabilities
Common Stock subject to possible redemption, 11,500,000 and no shares at redemption value of $10.10 at September 30, 2021 and December 31, 2020, respectively
Stockholders equity
Preferred stock
Preferred Series A
Series B Preferred Stock
Total preferred stock
Common stock; $0.0001 par value; 800,000,000 shares authorized at June 30, 2026 and December 31, 2025; 83,547,733 and 47,664,564 shares issued at June 30, 2026 and December 31, 2025, respectively, and 83,493,068 and 47,609,899 outstanding at June 30, 2026 and December 31, 2025, respectively
Treasury stock, at cost; 54,665 shares held at June 30, 2026 and December 31, 2025, respectively
Additional paid-in capital
Accumulated other comprehensive income (loss)
Accumulated deficit
Total stockholders' equity
Total liabilities and stockholders' equity

Comments